C. Kortsik

T Cells and Cytokines in Bronchoalveolar Lavage Fluid after Segmental Allergen Provocation in Atopic Asthma

J. Christian Virchow, Christoph Walker, D. Häfner et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 217 citations

Asthma, Lung Inflammation, Allergy Medicine +16

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma

C. Manegold, James T. Symanowski, U. Gatzemeier et al. · Annals of Oncology · 2005 · 157 citations

Malignant Pleural Mesothelioma, Medicine, Phase Iii Trial +6

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Giorgio V. Scagliotti, C. Kortsik, G. Dark et al. · Clinical Cancer Research · 2005 · 137 citations · Full text

The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial

Martin Sebastian, Martin Reck, Cornelius F. Waller et al. · Journal of Thoracic Oncology · 2010 · 109 citations · Full text

Bi 2536, Novel Plk-1 Inhibitor, Medicine +6

Highly Focused T Cell Responses in Latent Human Pulmonary <i>Mycobacterium tuberculosis</i> Infection

Glenn Tully, C. Kortsik, Hanni Höhn et al. · The Journal of Immunology · 2005 · 102 citations

Adaptive Immune System, Tuberculosis Prevention, Immunology +16